Insulin costs have declined over the past two years, and additional price cuts are expected in 2026. Medicare will lower prices for several diabetes drugs, including Januvia and Jardiance. Federal and ...

The healthcare industry has proven to be a resilient place for investors to put cash to work over the years. If you are looking for stocks to buy and hold for 30 years, here are two no-brainer names ...

Netherlands site will bring 500 manufacturing and 1,500 construction jobs while further strengthening Lilly's global supply ...

Denmark's Novo Nordisk said on Monday it is confident that its proposed takeover of U.S. drugmaker Metsera does not raise any antitrust issues.

There are strict rules about what drug companies can say in TV or print ads. But a new study shows there's a lot more wiggle room when companies pay to sponsor online search results.

Third quarter earnings season is in full swing, and analysts expect S&P 500 companies grew their profits by 8% during the ...

It's difficult to beat stocks as an investment. No, seriously. Just ask investors of other assets, because they've tried, and ...

The suit escalates a battle between Pfizer and Novo Nordisk over Metsera, whose obesity pipeline could yield new competitors in the weight loss drug market.

Metsera's shareholders are scheduled to meet on November 13 to decide on Novo Nordisk's offer of around $8.5 billion, while ...

Eli Lilly is investing €2.6billion in a new Dutch factory, bringing around 500 jobs and a major boost to the Dutch biotech scene.

Eli Lilly has a leading position in a hot new drug category, but there's one notable problem to consider.

Lilly said the plant will strengthen its global supply chain and expand the capacity for its growing portfolio of oral ...